Biopharma Informatic Inc.

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Ulcerative colitis2 trials
• Crohn's disease1 trial

Phase

• Phase 32 trials

Status

• Completed2 trials

Lead sponsor

• Eli Lilly and Company1 trial
• Shire1 trial

Closed trials

• Completed

  An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

  NCT03518086· Phase 3· Eli Lilly and Company· Source

• Completed

  A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)

  NCT03283085· Phase 3· Shire· Source